Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
“There’s an app for that.” The phrase became something of a mantra in the early smartphone era, as apps went from niche to mainstream after Apple opened its App Store in July 2008 and Android Market…
Read the full articleYou might also wanna read
A visual, intuition-driven introduction to information theory and its core concepts
arxiv.org·5h ago
DataSTORM: An LLM Agent System for Deep Research on Large-Scale Structured Databases
arxiv.org·19h agoIU Simon Comprehensive Cancer Center Showcases Eight Abstracts and Posters at AACI 2026
OncoDaily·1d ago
Moderna bets on mRNA’s second act with cancer, autoimmune programs and AI research platform
drugdiscoverytrends.com·2d ago
CU Anschutz Clinical Trial Tests Orforglipron, an Oral GLP-1 Pill as Alternative to Injectable Weight-Loss Drugs
news.cuanschutz.edu·2d ago
Why Over-Reliance on Pearson Correlation Is a Flawed Approach in Modern Data Science
valeman.medium.com·4d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.